Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Nascent Biotech Inc. (NBIO)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nascent Biotech Inc. since year 2005.
Table 2 shows the detailed insider transactions of Nascent Biotech Inc. since 2005.
The reporting company's ticker symbol is NBIO. The reporting company's CIK number is 1622057.
The total value of stock buying since 2005 is $3,294,733.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-12-01||Holden Lowell Thomas (CFO)||Buy||5,000||.17||825|
|2019-10-01||Holden Lowell Thomas (CFO)||Buy||10,000||.14||1,400|
|2015-10-01||Carrick Sean (Principal Executive Officer)||Buy||1,500||.20||300|
|2015-09-01||Carrick Sean (Principal Executive Officer)||Buy||1,028,901||1.45||1,491,906|
|2015-09-01||Price Brandon (Senior VP Business Development)||Buy||617,346||1.45||895,151|
|2015-09-01||Holden Lowell Thomas (CFO)||Buy||617,346||1.45||895,151|
|2015-04-01||Karas Douglas John||Buy||10,000||1.00||10,000|
Insider trading activities including stock purchases, stock sales, and option exercises of NBIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nascent Biotech Inc. (symbol NBIO, CIK number 1622057) see the Securities and Exchange Commission (SEC) website.